We here set out to review the literature of the past 20 years on the reciprocal interaction of TIGIT and the T cell metabolism, how it affects anti-tumor immunity, and how a better understanding of this interaction can pave the way for improved immunotherapy to treat cancer. The gene discussed is TIGIT; the disease is neoplasm.